[an error occurred while processing this directive]

Prescribing Information

Instructions for Use

Prescribing Information

Instructions for Use

NEMLUVIO relieves itch fast with clearer skin that lasts1-3*

GET SUPPORT

For continued relief from chronic itch, take NEMLUVIO® as your doctor recommends

Fast itch relief, in some people, as soon as 48 hours2,3†

Long-lasting skin clearance2,3

~Once-monthly dosing from the start4

*

At 16 and 48 weeks, many on NEMLUVIO saw clear or almost clear skin.

†Results were achieved at 48 hours in 10.7% of patients with NEMLUVIO + TCS/TCI vs 2.9% with placebo + TCS/TCI. Data are from pooled post-hoc analysis of daily itch improvement reported in Phase 3 clinical studies. Itch improvement was defined as ≥4‑point improvement from baseline (PP‑NRS scale). Do not make conclusions based on these results.

References: 1. Ständer S, Elmariah SB, Kwatra SG, et al. Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies. J Eur Acad Dermatol Venereol. 2025;00:1–9. doi:10.1111/jdv.70250 2. Augustin M, Tauber M, Sidbury R, et al. Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study. J Eur Acad Dermatol Venereol. 2025;00:1–15. doi:10.1111/jdv.70080 3. Legat FJ, Kwatra SG, Reich A, et al. Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis. J Eur Acad Dermatol Venereol. 2025;00:1–13. doi:10.1111/jdv.70266 4. NEMLUVIO (nemolizumab-ilto) Injection 30 mg Prescribing Information. Dallas, TX: Galderma Laboratories, L.P.

Stay on track with GPS for NEMLUVIO®

GPS (Galderma Patient Services) for NEMLUVIO® is a free program that offers access to different patient services to help you start NEMLUVIO treatment.

Not an actual patient.

[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive]
[an error occurred while processing this directive]